Barba-Rosado L, Carrascal-Hernandez D, Insuasty D, Grande-Tovar C
Nanomaterials (Basel). 2024; 14(2).
PMID: 38251150
PMC: 10820493.
DOI: 10.3390/nano14020186.
Parchami M, Haghiralsadat F, Sadeghian-Nodoushan F, Hemati M, Shahmohammadi S, Ghasemi N
Heliyon. 2023; 9(5):e15495.
PMID: 37153425
PMC: 10160703.
DOI: 10.1016/j.heliyon.2023.e15495.
Feng W, Lin H, Rothzerg E, Song D, Zhao W, Ning T
Cancer Inform. 2023; 22:11769351231161478.
PMID: 37101729
PMC: 10123892.
DOI: 10.1177/11769351231161478.
Van Stiphout C, Luu A, Viloria-Petit A
Cancers (Basel). 2022; 14(19).
PMID: 36230467
PMC: 9559645.
DOI: 10.3390/cancers14194544.
Bai B, Wu Z, Weng S, Yang Q
Cancer Med. 2022; 12(4):5025-5034.
PMID: 36082478
PMC: 9972029.
DOI: 10.1002/cam4.5225.
Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation.
Zhang H, Zhou Q, Shen W
J Orthop Surg Res. 2022; 17(1):344.
PMID: 35799265
PMC: 9261067.
DOI: 10.1186/s13018-022-03207-0.
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients.
Molina E, Chim L, Lamhamedi-Cherradi S, Mohiuddin S, McCall D, Cuglievan B
Oncotarget. 2022; 13:521-533.
PMID: 35284040
PMC: 8906536.
DOI: 10.18632/oncotarget.28215.
The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma.
Yu B, Liu L, Cai F, Peng Y, Tang X, Zeng D
Cancer Cell Int. 2022; 22(1):64.
PMID: 35135529
PMC: 8822767.
DOI: 10.1186/s12935-022-02443-y.
Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines.
Xu E, Jiang H, Lin T, Meng Y, Ma X, Yin J
Transl Cancer Res. 2022; 9(3):1795-1805.
PMID: 35117527
PMC: 8799049.
DOI: 10.21037/tcr.2020.02.25.
A Web-Based Prediction Model for Overall Survival of Elderly Patients With Malignant Bone Tumors: A Population-Based Study.
Tang J, Wang J, Pan X
Front Public Health. 2022; 9:812395.
PMID: 35087789
PMC: 8787310.
DOI: 10.3389/fpubh.2021.812395.
Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
Xu L, Tan Y, Xu F, Zhang Y
Bioengineered. 2022; 13(2):2028-2043.
PMID: 35030964
PMC: 8973676.
DOI: 10.1080/21655979.2021.2019872.
MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660.
Shan H, Zhu L, Yao C, Zhang Z, Liu Y, Jiang Q
Mol Ther Nucleic Acids. 2021; 24:385-402.
PMID: 33868783
PMC: 8039776.
DOI: 10.1016/j.omtn.2021.03.006.
Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1.
Han F, Pu P, Wang C, Ding X, Zhu Z, Xiang W
Biomed Res Int. 2021; 2021:7358153.
PMID: 33834074
PMC: 8016573.
DOI: 10.1155/2021/7358153.
Circ_WWC3 overexpression decelerates the progression of osteosarcoma by regulating miR-421/PDE7B axis.
Liu S, Zhang J, Zheng T, Mou X, Xin W
Open Life Sci. 2021; 16(1):229-241.
PMID: 33817314
PMC: 7968534.
DOI: 10.1515/biol-2021-0021.
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
Marchandet L, Lallier M, Charrier C, Baudhuin M, Ory B, Lamoureux F
Cancers (Basel). 2021; 13(4).
PMID: 33567616
PMC: 7915189.
DOI: 10.3390/cancers13040683.
circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
Wan J, Liu Y, Long F, Tian J, Zhang C
Cancer Sci. 2020; 112(5):1707-1722.
PMID: 33369809
PMC: 8088910.
DOI: 10.1111/cas.14787.
Bone Microenvironment and Osteosarcoma Metastasis.
Yang C, Tian Y, Zhao F, Chen Z, Su P, Li Y
Int J Mol Sci. 2020; 21(19).
PMID: 32977425
PMC: 7582690.
DOI: 10.3390/ijms21196985.
p38γ overexpression promotes osteosarcoma cell progression.
Shi C, Cheng W, Wang Y, Li D, Zhou L, Zhu Y
Aging (Albany NY). 2020; 12(18):18384-18395.
PMID: 32970611
PMC: 7585114.
DOI: 10.18632/aging.103708.
Integrated analysis of lncRNA-associated ceRNA network identified potential regulatory interactions in osteosarcoma.
Wang Y, Gao Y, Guo S, Chen Z
Genet Mol Biol. 2020; 43(2):e20190090.
PMID: 32453338
PMC: 7252519.
DOI: 10.1590/1678-4685-GMB-2019-0090.
Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway.
Yang S, Chen J, Tan T, Wang N, Huang Y, Wang Y
Cancer Manag Res. 2020; 12:2875-2888.
PMID: 32425601
PMC: 7196244.
DOI: 10.2147/CMAR.S238093.